Corticosteroids in Severe Sepsis

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Clinical Pulmonary Medicine

• Publication date

  2001-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00045413-200109000-00003
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin.

  2000cited by this paper
• Effect of hydrocortisone on phenylephrine– mean arterial pressure dose‐response relationship in septic shock

  2000cited by this paper
• HYDROCORTISONE REVERSES REFRACTORY SEPTIC SHOCK

  1999cited by this paper
• Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study.

  1999cited by this paper
• Treating patients with severe sepsis.

  1999cited by this paper
• Effects of topical corticosteroids on inflammatory mediator-induced eicosanoid release by human airway epithelial cells.

  1999cited by this paper
• Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve.

  1998cited by this paper
• CORTISOL AND HYPERTENSION

  1998cited by this paper
• Reversal of late septic shock with supraphysiologic doses of hydrocortisone.

  1998cited by this paper
• Dose-response relationships and mineralocorticoid activity in cortisol-induced hypertension in humans.

  1996cited by this paper
• Hypercortisolemia increases plasma interleukin-10 concentrations during human endotoxemia--a clinical research center study.

  1996influential reference
• Local venous responses to endotoxin in humans.

  1996cited by this paper
• Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature.

  1995cited by this paper
• Annual summary of births marriages divorces and deaths: United States 1994.

  1995cited by this paper
• Immunosuppression by Glucocorticoids: Inhibition of NF-κB Activity Through Induction of IκB Synthesis

  1995cited by this paper
• Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids

  1995cited by this paper
• Influence of hypercortisolemia on soluble tumor necrosis factor receptor II and interleukin-1 receptor antagonist responses to endotoxin in human beings.

  1995cited by this paper
• The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation.

  1995cited by this paper
• Adrenal insufficiency occurring during septic shock: incidence, outcome, and relationship to peripheral cytokine levels.

  1995cited by this paper
• Steroid controversy in sepsis and septic shock: a meta-analysis.

  1995cited by this paper
• Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression.

  1994cited by this paper
• Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor.

  1994cited by this paper
• Molecular mechanisms of action of steroid/thyroid receptor superfamily members.

  1994cited by this paper
• Modulation of IL-1-induced neutrophil migration by dexamethasone and lipocortin 1.

  1993cited by this paper
• Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man.

  1993cited by this paper
• Effect of dexamethasone on the onset and persistence of vascular hyporeactivity induced by E. coli lipopolysaccharide in rats.

  1993cited by this paper
• The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis.

  1991cited by this paper
• Cortisol response to corticotropin and survival in septic shock.

  1991cited by this paper
• Dexamethasone inhibits the induction of monocyte chemotactic-activating factor production by IL-1 or tumor necrosis factor.

  1991cited by this paper
• Cortisol response to corticotropin and survival in septic shock

  1991cited by this paper
• Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A double-blind, placebo-controlled trial.

  1990cited by this paper
• Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo.

  1990cited by this paper
• Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages.

  1990cited by this paper
• Biological and clinical aspects of interleukin 6.

  1990cited by this paper
• Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells.

  1990cited by this paper
• Transcription factor interactions: selectors of positive or negative regulation from a single DNA element.

  1990cited by this paper
• Corticosteroids suppress cyclooxygenase messenger RNA levels and prostanoid synthesis in cultured vascular cells.

  1988cited by this paper
• Negative regulation by glucocorticoids through interference with a cAMP responsive enhancer.

  1988cited by this paper
• Glucocorticoids modulate vascular reactivity in the rat.

  1987cited by this paper
• Corticosteroid/antibiotic treatment of adrenalectomized dogs challenged with lethal E. coli.

  1985cited by this paper
• The Cardiopulmonary Response to Massive Doses of Steroids in Patients with Septic Shock

  1984cited by this paper
• The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study.

  1984cited by this paper
• Reduction of mortality in chloramphenicol-treated severe typhoid fever by high-dose dexamethasone.

  1984cited by this paper
• The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. II. Clinical observations, with special reference to factors influencing prognosis.

  1983cited by this paper
• Cortisol replacement in severely stressed patients.

  1983cited by this paper
• Steroid therapy in septic shock. Survival studies in a laboratory model.

  1982cited by this paper
• Steroids in the Treatment of Clinical Septic Shock

  1976cited by this paper
• Letter: Parkinsonism induced by fluphenazine decanoate.

  1976cited by this paper
• Clinical trial design in studies of corticosteroids for bacterial infections.

  1974cited by this paper
• Studies on the mechanism of hydrocortisone potentiation of vasoconstrictor responses to epinephrine in the anesthetized animal.

  1974cited by this paper
• Carcinoid syndrome. Serotonin release induced with intravenous adrenaline or noradrenaline.

  1961cited by this paper
• SUPRARENAL CORTICAL HORMONE AND SALT IN THE TREATMENT OF PNEUMONIA AND OTHER SEVERE INFECTIONS

  1940cited by this paper
• A CASE OF SUPRARENAL APOPLEXY.

  1911cited by this paper

• Compartmental Model Suggests Importance of Innate Immune Response to COVID-19 Infection in Rhesus Macaques

  2021cites this paper
• Corticosteroids and Community-Acquired Pneumonia

  2003cites this paper
• The Brain in Sepsis

  2003cites this paper
• 36 THE BRAIN IN SEPSIS

  year unknowncites this paper